Novel halogenated sulfonamides inhibit the growth of multidrug resistant MCF-7/ADR cancer cells

被引：91

作者：

Medina, JC ^{[1
]}

Roche, D ^{[1
]}

Shan, B ^{[1
]}

Learned, RM ^{[1
]}

Frankmoelle, WP ^{[1
]}

Clark, DL ^{[1
]}

Rosen, T ^{[1
]}

Jaen, JC ^{[1
]}

机构：

[1] Tularik Inc, S San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 1999年 / 9卷 / 13期

关键词：

D O I：

10.1016/S0960-894X(99)00276-0

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

In this report, we describe the synthesis of halogenated benzenesulfonamide compounds and their ability to inhibit the growth of HeLa, MCF-7 and MCF-7/ADR tumor cells in vitro. The multidrug resistance (MDR) phenotype of certain cells does not affect their sensitivity to these compounds. These agents belong to a family of compounds previously shown to bind irreversibly to cysteine-239 of beta-tubulin. Consistent with this mechanism of action, the cytotoxicities of these compounds appear to correlate with their ability to undergo nucleophilic aromatic substitution. (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：1843 / 1846

页数：4

共 50 条

[21] Comparison of cell membrane damage induced by the therapeutic ultrasound on human breast cancer MCF-7 and MCF-7/ADR cells
Jia, Yali
Yuan, Wenjuan
Zhang, Kun
Wang, Juan
Wang, Pan
Liu, Quanhong
Wang, Xiaobing
ULTRASONICS SONOCHEMISTRY, 2015, 26 : 128 - 135
[22] Cytotoxic and chemomodulatory effects of Phyllanthus niruri in MCF-7 and MCF-7ADR breast cancer cells
Abdel-Sattar, Ola E. E.
Allam, Rasha Mosa
Al-Abd, Ahmed M. M.
Avula, Bharathi
Katragunta, Kumar
Khan, Ikhlas A. A.
El-Desoky, Ahmed M. M.
Mohamed, Shanaz O. O.
El-Halawany, Ali
Abdel-Sattar, Essam
Meselhy, Meselhy R. R.
SCIENTIFIC REPORTS, 2023, 13 (01)
[23] Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools
Jack S.K. Chen
Neeraj Agarwal
Kapil Mehta
Breast Cancer Research and Treatment, 2002, 71 : 237 - 247
[24] Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools
Chen, JSK
Agarwal, N
Mehta, K
BREAST CANCER RESEARCH AND TREATMENT, 2002, 71 (03) : 237 - 247
[25] Formononetin and metformin act synergistically to inhibit growth of MCF-7 breast cancer cells in vitro
Xin, Min
Wang, Yong
Ren, Qianyao
Guo, Yanhong
BIOMEDICINE & PHARMACOTHERAPY, 2019, 109 : 2084 - 2089
[26] Novel microtubule inhibitor SQ overcomes multidrug resistance in MCF-7/ ADR cells by inhibiting BCRP function and mediating apoptosis
Chang, Xing
Liu, Zi
Cao, Simeng
Bian, Jiang
Zheng, Dayong
Wang, Nuo
Guan, Qi
Wu, Yingliang
Zhang, Weige
Li, Zengqiang
Zuo, Daiying
TOXICOLOGY AND APPLIED PHARMACOLOGY, 2022, 436
[27] Structure-activity relationships of diverse Annonaceous acetogenins against multidrug resistant human mammary adenocarcinoma (MCF-7/Adr) cells
Oberlies, NH
Chang, CJ
McLaughlin, JL
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (13) : 2102 - 2106
[28] Comparison of staurosporine and four analogues: Their effects on growth, rhodamine 123 retention and binding to P-glycoprotein in multidrug-resistant MCF-7/Adr cells
Budworth, J
Davies, R
Malkhandi, J
Gant, TW
Ferry, DR
Gescher, A
BRITISH JOURNAL OF CANCER, 1996, 73 (09) : 1063 - 1068
[29] Reversal effects of two new milbemycin compounds on multidrug resistance in MCF-7/adr cells in vitro
Gao, Aili
Liang, Hongsheng
Wang, Xiangjing
Zhang, Xiangtong
Jing, Meng
Zhang, Ji
Yan, Yijun
Xiang, Wensheng
EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 659 (2-3) : 108 - 113
[30] A novel compound RY10-4 downregulates P-glycoprotein expression and reverses multidrug-resistant phenotype in human breast cancer MCF-7/ADR cells
Xue, Pingping
Yang, Xiaofan
Liu, Yang
Xiong, Chaomei
Ruan, Jinlan
BIOMEDICINE & PHARMACOTHERAPY, 2014, 68 (08) : 1049 - 1056

← 1 2 3 4 5 →